<DOC>
	<DOCNO>NCT02437526</DOCNO>
	<brief_summary>This study design determine individual patient HIV infection cure infection . To , antiretroviral therapy discontinue close medical supervision patient monitor time reactivation infection .</brief_summary>
	<brief_title>Analytic Treatment Interruption ( ATI ) Assess HIV Cure</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Age ≥ 18 year HIV1 infect potential cured infection course routine clinical care opinion treat physician study team Have undetectable plasma HIV1 RNA undetectable proviral DNA suppressive antiretroviral therapy least two consecutive measure least 6 month Able willing either abstain sexual activity use barrier contraceptive ATI Negative serum βHCG pregnancy test woman childbearing potential Have ability give appropriate inform consent . Exclusion Criteria Women pregnant nursing Women become pregnant unable unwilling use barrier pharmacologic contraceptive ATI Previous current infection high risk reactivate immune suppression , effective antimicrobial prophylaxis option Advanced cardiopulmonary liver disease History untreated solid hematologic malignancy Evidence active viral replication patient coinfected Hepatitis B virus ( HBV ) . Treatment provide suppress HBV replication agent activity HIV ( ie entecavir ) prior consideration ATI . Evidence viral replication Hepatitis C virus ( HCV ) , together evidence hepatic fibrosis inflammation . Such patient offer HCV treatment first .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cure</keyword>
	<keyword>Analytic treatment interruption</keyword>
</DOC>